CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-30 | PYSZCZYMUKA GREG Chief Commerical Officer | Option exercise | +208 | 22,143 | ||
| 2023-06-30 | PYSZCZYMUKA GREG Chief Commerical Officer | Option exercise · Restricted Stock Units | −208 | 1,459 | ||
| 2023-06-16 | PYSZCZYMUKA GREG Chief Commerical Officer | Purchase | +12,000 | $1.87 | $22K | 21,935 |
| 2023-06-14 | Disbrow Joshua R. Chief Executive Officer | Purchase | +14,000 | $1.86 | $26K | 71,591 |
| 2023-04-25 | PYSZCZYMUKA GREG Chief Commerical Officer | Option exercise | +833 | 9,935 | ||
| 2023-04-25 | PYSZCZYMUKA GREG Chief Commerical Officer | Option exercise · Restricted Stock Units | −833 | 1,667 | ||
| 2023-02-08 | LIU VIVIAN H Director | Grant or award | +6,500 | 6,825 | ||
| 2022-12-21 | Donofrio John Jr. Director | Returned to the company | −187,804 | 15,267 | ||
| 2022-12-21 | Cantrell Gary Director | Returned to the company | −40,000 | 164,089 | ||
| 2022-12-21 | DOCKERY CARL Director | Returned to the company | −40,000 | 148,805 | ||
| 2022-12-20 | Disbrow Joshua R. Chief Executive Officer | Returned to the company | −80,000 | 1,151,877 | ||
| 2022-12-19 | Disbrow Joshua R. Chief Executive Officer | Purchase | +112,371 | $0.22 | $25K | 1,231,877 |
| 2022-12-19 | PYSZCZYMUKA GREG Chief Commercial Officer | Purchase | +100,000 | $0.24 | $24K | 182,056 |
| 2022-11-18 | Disbrow Joshua R. Chief Executive Officer | Purchase | +222,000 | $0.24 | $53K | 1,119,506 |
| 2022-11-18 | Oki Mark K Chief Financial Officer | Purchase | +90,000 | $0.23 | $21K | 190,000 |
| 2022-11-18 | Disbrow Joshua R. Chief Executive Officer | Grant or award | +222,000 | $0.24 | $53K | 1,119,506 |
| 2022-11-18 | Oki Mark K Chief Financial Officer | Grant or award | +90,000 | $0.23 | $21K | 190,000 |
| 2022-07-01 | LIU VIVIAN H Director | Grant or award | +6,500 | 6,500 | ||
| 2022-01-17 | Oki Mark K Chief Financial Officer | Grant or award | +100,000 | 100,000 | ||
| 2021-04-16 | DOCKERY CARL Director | Grant or award | +187,804 | 188,805 |
Page 4 of 15 · 300 trades